Development status of typhoid conjugate vaccines globally

S. Sahastrabuddhe
International Journal of Infectious Diseases 45 65

2016
Epidemiology of typhoid fever

L. Ochiai , M.I. Khan , S. Sahastrabuddhe , T. Wierzba
International Journal of Infectious Diseases 16

2
2012
Role of vaccination in preventing typhoid fever: experience from Vietnam

S. Sahastrabuddhe , U. Panzner , V.D. Thiem , T. Wierzba
International Journal of Infectious Diseases 16 e360

2012
Typhoid Fever surveillance and vaccine use - South-East Asia and Western Pacific regions, 2009-2013.

Eric D Mintz , Terri B Hyde , Kimberley K Fox , Kashmira A Date
Morbidity and Mortality Weekly Report 63 ( 39) 855 -860

22
2014
Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal.

Suchada Chinaworapong , Sonali Palkar , Tarun Saluja , Shipra Chaudhary
Human Vaccines & Immunotherapeutics 1 -9

2021
Spectroscopic characterisation of a series of Salmonella Typhi Vi-diphtheria toxoid glycoconjugate antigens differing in polysaccharide-protein ratio.

Christopher Jones , So Jung An , Yeon Kyung Yoon , Sudeep Kothari
Journal of Pharmaceutical and Biomedical Analysis 181 113100

3
2020
7
2013
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report

Bernie Endyarni Medise , Soedjatmiko Soedjatmiko , Hartono Gunardi , Rini Sekartini
BMC Pediatrics 20 ( 1) 480

2020
Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children

Maria Rosario Capeding , Samuel Teshome , Tarun Saluja , Khalid Ali Syed
Vaccine 36 ( 26) 3794 -3801

20
2018
18
2018
Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.

Mi Seon Jang , Sushant Sahastrabuddhe , Cheol-Heui Yun , Seung Hyun Han
Microbial Pathogenesis 97 19 -26

12
2016
The Need for an Information Communication and Advocacy Strategy to Guide a Research Agenda to Address Burden of Invasive Nontyphoidal Salmonella Infections in Africa.

M. Imran Khan , Alexander J. Freeman , Bradford D. Gessner , Sushant Sahastrabuddhe
Clinical Infectious Diseases 61

2
2015
Status of paratyphoid fever vaccine research and development.

Laura B. Martin , Raphael Simon , Calman A. MacLennan , Sharon M. Tennant
Vaccine 34 ( 26) 2900 -2902

28
2016
Typhoid vaccine introduction: an evidence-based pilot implementation project in Nepal and Pakistan

M. Imran Khan , Alfred Pach , Ghulam Mustafa Khan , Deepak Bajracharya
Vaccine 33 ( 3)

5
2015
Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead.

Khalid Ali Syed , Tarun Saluja , Heeyoun Cho , Amber Hsiao
Clinical Infectious Diseases 71

3
2020
25 Years after Vi Typhoid Vaccine Efficacy Study, Typhoid Affects Significant Number of Population in Nepal

Deepak Bajracharya Deepak Bajracharya , MI Khan , A , III Pach
PLoS ONE 9 ( 1) e77974

9
2014
Spatial and Temporal Patterns of Typhoid and Paratyphoid Fever Outbreaks: A Worldwide Review, 1990-2018.

Samuel Kim , Kang Sung Lee , Gi Deok Pak , Jean-Louis Excler
Clinical Infectious Diseases 69

7
2019
Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans

Sushant Sahastrabuddhe , Tarun Saluja
Clinical Infectious Diseases 68

23
2019
Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.

Sushant Sahastrabuddhe , Rodney Carbis , Thomas F Wierzba , R Leon Ochiai
Expert Review of Vaccines 12 ( 9) 1021 -1031

41
2013